These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22193838)

  • 21. Pharmacoeconomics of atrial fibrillation and stroke prevention.
    Bushnell CD; Matchar DB
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S66-71. PubMed ID: 15152748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Left atrial appendage elimination using Amplatzer Cardiac Plug in patients with atrial fibrillation - report of two cases].
    Plewka M; Kasprzak JD; Peruga JZ; Park JW; Lipiec P
    Kardiol Pol; 2011; 69(1):85-7; discussion 88. PubMed ID: 21267978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of cardioembolic stroke in patients with atrial fibrillation.
    Weber R; Diener HC; Weimar C
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic therapy for stroke prevention in atrial fibrillation.
    Go AS; Fang MC; Singer DE
    Prog Cardiovasc Dis; 2005; 48(2):108-24. PubMed ID: 16253651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
    Deedwania PC; Huang GW
    Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous left atrial appendage closure.
    Bertog SC; Franke J; Wunderlich N; Hofmann I; Sievert H
    Herz; 2011 Sep; 36(6):551-4. PubMed ID: 21938610
    [No Abstract]   [Full Text] [Related]  

  • 30. [Percutaneous left atrial appendage closure with Watchman® LAA occluder device in a patient with persistent atrial fibrillation].
    Kleczyński P; Sorysz D; Zawiślak B; Arif S; Bartuś S; Legutko J; Dubiel J; Dudek D
    Kardiol Pol; 2012; 70(9):965-7. PubMed ID: 22993014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New anticoagulants for the prevention of stroke in atrial fibrillation.
    Höchtl T; Huber K
    Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke prevention in atrial fibrillation.
    Verheugt FW
    Neth J Med; 2006 Feb; 64(2):31-3. PubMed ID: 16517985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis on a left atrial appendage occluder device: the double-edged sword of stroke prevention strategies in atrial fibrillation.
    Ciconte G; Conti M; Baldi M; Saviano M; Vicedomini G; Pappone C
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):920-921. PubMed ID: 28937581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter occlusion of the left atrial appendage for stroke prevention.
    Bayard YL; Ostermayer SH; Sievert H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1003-8. PubMed ID: 16292991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment strategies for prevention of cardioembolic stroke in atrial fibrillation.
    Park JW; Leithäuser B; Rittger H; Brachmann J
    Clin Hemorheol Microcirc; 2010; 46(4):251-64. PubMed ID: 21187574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training].
    Casu G; Gulizia MM; Molon G; Mazzone P; Audo A; Casolo G; Di Lorenzo E; Portoghese M; Pristipino C; Ricci RP; Themistoclakis S; Padeletti L; Tondo C; Berti S; Oreglia JA; Gerosa G; Zanobini M; Ussia GP; Musumeci G; Romeo F; Di Bartolomeo R
    G Ital Cardiol (Rome); 2016; 17(7-8):594-613. PubMed ID: 27571335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
    Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S
    Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.